Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes.

Senthi S, Haasbeek CJ, Lagerwaard FJ, Verbakel WF, de Haan PF, Slotman BJ, Senan S.

J Thorac Dis. 2013 Apr;5(2):116-22. doi: 10.3978/j.issn.2072-1439.2013.02.07.

2.

Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53. doi: 10.1016/j.ijrobp.2011.06.2003. Epub 2011 Nov 19.

PMID:
22104360
3.

Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.

Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez DR, Komaki R, Roth JA, Swisher SG.

Cancer. 2013 Sep 15;119(18):3402-10. doi: 10.1002/cncr.28217. Epub 2013 Jun 24.

4.

Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.

Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):318-28.

PMID:
15667949
5.

Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.

Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang TC, Fujita K, Oita M, Miyasaka K, Nishimura M, Dosaka-Akita H.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):126-35.

PMID:
12694831
6.

Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.

Haasbeek CJ, Lagerwaard FJ, de Jaeger K, Slotman BJ, Senan S.

Cancer. 2009 Feb 1;115(3):587-94. doi: 10.1002/cncr.24068.

7.

Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.

Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, Jeremic B.

Lung Cancer. 2005 Apr;48(1):107-14. Epub 2004 Dec 19.

PMID:
15777977
8.

Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.

Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, Le QT, Loo BW Jr, Diehn M.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):231-7. doi: 10.1016/j.ijrobp.2011.10.071. Epub 2012 Feb 28.

PMID:
22381907
9.

Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.

Fukumoto S, Shirato H, Shimzu S, Ogura S, Onimaru R, Kitamura K, Yamazaki K, Miyasaka K, Nishimura M, Dosaka-Akita H.

Cancer. 2002 Oct 1;95(7):1546-53.

10.

[An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].

Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.

Cancer Radiother. 2013 Jul-Aug;17(4):272-81. doi: 10.1016/j.canrad.2013.01.021. Epub 2013 May 24. French.

PMID:
23712043
11.

Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame.

Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, Araki N, Mitsumori M, Sasai K, Shibamoto Y, Koga S, Yano S, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1041-6.

PMID:
11958900
12.

Curative radiotherapy for a second primary lung cancer arising after pneumonectomy -- techniques and results.

Lagerwaard FJ, Voet PW, van Meerbeeck JP, Burgers SA, Senan S; Rotterdam Oncological Thoracic Study Group.

Radiother Oncol. 2002 Jan;62(1):21-5.

PMID:
11830309
13.

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1427-31. Epub 2005 Sep 19.

PMID:
16169670
14.

Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.

Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Lin A, Schipper MJ, Wolf GT.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):28-42.

PMID:
15093896
15.

Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.

Lee DS, Kim YS, Yoo IeR, Kang YN, Kim SJ, Oh JK, Kim YK, Wang YP, Park JG, Kang JH, Han DH, Ahn MI, Lee KY.

Lung Cancer. 2013 May;80(2):172-8. doi: 10.1016/j.lungcan.2012.12.023. Epub 2013 Feb 8.

PMID:
23489556
16.

Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.

Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1017-23. doi: 10.1016/j.ijrobp.2012.02.020. Epub 2012 Apr 27.

17.

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.

Uitterhoeve AL, Belderbos JS, Koolen MG, van der Vaart PJ, Rodrigus PT, Benraadt J, Koning CC, González González D, Bartelink H.

Eur J Cancer. 2000 Mar;36(5):592-600.

PMID:
10738123
18.

Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting.

Heal C, Ding W, Lamond J, Wong M, Lanciano R, Su S, Yang J, Feng J, Arrigo S, Markiewicz D, Hanlon A, Brady L.

Front Oncol. 2015 Jun 30;5:146. doi: 10.3389/fonc.2015.00146. eCollection 2015.

19.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
20.

Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):149-54.

PMID:
9422571
Items per page

Supplemental Content

Write to the Help Desk